PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Pl, Box 1185, New York, NY, 10029, USA. Deepu.Madduri@mountsinai.org.\', \'Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Pl, Box 1185, New York, NY, 10029, USA.\', \'Bristol-Myers Squibb, Princeton, NJ, USA.\', \'bluebird bio, Cambridge, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13256-020-02598-0
?:doi
?:hasPublicationType
?:journal
  • Journal of medical case reports
is ?:pmid of
?:pmid
?:pmid
  • 33608053
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.331
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all